The medical device clinical trial management exchange meeting was held in Beijing

Notice of the General Department of the State Food and Drug Administration on matters related to the change of product instructions of some in vitro diagnostic reagents

Opinions of the State Food and Drug Administration on further strengthening and improving the classified management of medical devices

The vascular plaque atherectomy control device and the disposable peripheral vascular plaque atherectomy catheter were approved for marketing

Transcatheter aortic valve system was approved for marketing

The hepatitis B virus surface antigen (HBsAg) detection kit was approved for marketing

The navigation and positioning microwave ablation system was approved for marketing

Interpretation of the classification and definition of radiofrequency therapy instruments and radiofrequency skin therapy devices